Miral, Junielyn H.

HRN: 23-03-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2025
AMPICILLIN 1GM (VIAL)
12/15/2025
12/16/2025
IV
2gram
Q6
G2P1 (1001) PU 41 2/7 Weeks
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: